Teva Recalls Desmopressin Acetate Tablets Due to Missing Desiccant
Teva Pharmaceuticals USA is recalling Desmopressin Acetate Tablets because bottles may be missing desiccant, a GMP deviation.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II and involves a GMP deviation (missing desiccant) which is a low-risk contamination or stability issue without reported illness, fitting the Moderate criteria.
Plain-English summary
Teva Pharmaceuticals USA is recalling Desmopressin Acetate Tablets, 0.1 mg, 100-count bottles. The recall involves 22,868 bottles distributed nationwide within the United States. The specific lots affected are 1281203M (exp. 03/2020) and 1290113M (exp. 04/2020).
The reason for the recall is a Good Manufacturing Practice (GMP) deviation where the product bottle may be absent of desiccant. Desiccants are used to absorb moisture and maintain product stability.
Consumers and healthcare providers should check their inventory for the specific lot numbers and expiration dates listed above. If the product matches the recalled lots, it should be returned to the pharmacy or distributor for replacement or refund.
The recalled product
- Product
- Desmopressin Acetate Tablets, 0.1 mg, 100-count bottle, Rx Only, Manufactured by: Actavis Laboratories, Inc. Fort Lauderdale, FL 33314 USA, Distributed by: Actavis Pharma, Inc. Parisppany, NJ 07054 USA, NDC 0591-2464-01
- Manufacturer
- Teva Pharmaceuticals USA
- Category
- Drug — Prescription Medication
- Affected units
- 22,868
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (3)
- Lot #: 1281203M
- exp. date 03/2020 and 1290113M
- exp. date 04/2020
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 2 recalled by Teva Pharmaceuticals USA under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 2 products in this recall →Related recalls
Same manufacturer · Teva Pharmaceuticals USA
See all →- ModerateDoxylamine Succinate and Pyridoxine Hydrochloride Tablets Recalled for Failed Dissolution
FDA (Drugs) · 2022-02-09
- LowPrescription Drug Recall: Mimvey Mislabeling by Teva Pharmaceuticals
FDA (Drugs) · 2022-02-09
- ModerateTretinoin Capsules 10 mg Recalled for Failed Dissolution Specifications
FDA (Drugs) · 2022-02-09
- LowMimvey Estradiol/Norethindrone Prescription Drug Mislabeling Recall
FDA (Drugs) · 2022-02-09
- ModerateBrinzolamide Ophthalmic Suspension recalled for defective container caps
FDA (Drugs) · 2022-01-26
Same hazard · gmp deviation
See all →- HighPrazosin hydrochloride tablets recalled over nitrosamine impurity above limits
FDA (Drugs) · 2026-04-08
- HighPrazosin hydrochloride further lots recalled over nitrosamine impurity levels
FDA (Drugs) · 2026-04-08
- HighPrazosin hydrochloride 100-count bottles recalled over nitrosamine impurity
FDA (Drugs) · 2026-04-08
- ModerateFirst Aid Only hand sanitizing wipes recalled over manufacturing deviations
FDA (Drugs) · 2026-03-11
- ModerateFirst Aid Only BZK antiseptic towelettes recalled over manufacturing deviations
FDA (Drugs) · 2026-03-11